Deirdre Fuller, Oncology Roundtable
We recently attended the Institute of Medicine’s National Cancer Policy Forum workshop, "Delivering Affordable Cancer Care in the 21st Century," and we wanted to bring you some of the highlights.
Nothing new: America spending too much on health care
One of the workshop panelists was Dr. Ezekiel Emanuel, Chair of the Department of Medical Ethics and Health Policy at the University of Pennsylvania’s Perelman School of Medicine. During his presentation, Dr. Emmanuel noted that the U.S. spends $2.8 trillion on health care, which is roughly equivalent to the total GDP of France. While it is true that richer countries spend more on health care, America’s spending is incomparable to that of other developed nations.
Where are the costs in cancer care?
Marisa Deline, Oncology Roundtable
Reducing chemotherapy patient wait times by 80%
A recent report in Becker’s Hospital Review details how Cleveland Clinic’s Taussig Cancer Institute reduced chemotherapy patient wait times from approximately two hours to less than twenty minutes.
Reducing chemotherapy patient wait times by 80
For some reason, we've seen a big spike this week in questions about mid-level providers. Given that this is such a hot topic, I thought it might be helpful to post some excerpts from the discussions that my colleagues and I have been having.
You'll see that we don't have all of the answers so I would love to hear from you. How does your organization use NPs and PAs? How do you manage compensation? recruitment? retention? Are physicians compensated for supervising mid-levels? Please submit your comments and questions by completing the form at the bottom of this post.
How do other hospitals structure mid-level providers' compensation?
Based on my conversations with Roundtable members, most MLPs are salaried, and in some cases, they may be eligible for performance bonuses based on quality and/or productivity. However, given the breadth of MLPs' responsibilities, it can be difficult to develop adequate performance metrics.
FAQs about mid-level providers in oncology practice